Hemoglobin-based oxygen carriers for hemorrhagic shock

Resuscitation

Volumn 83, Issue 3, 2012, Pages 285-292

  Elmer, Jonathan ^a   Alam, Hasan B ^b   Wilcox, Susan R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood alternatives; Hemoglobin based oxygen carriers; Hemorrhagic shock; Transfusion

Indexed keywords

CO MP4; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN DERIVATIVE; HEMOGLOBIN GLUTAMER 256; HEMOSPAN; LIVER ENZYME; NITRIC OXIDE; PANCREAS ENZYME; PEGYLATED HEMOGLOBIN; POLYMERIZED HEMOGLOBIN; PYRIDOXYLATED HEMOGLOBIN POLYOXYLETHYLENE CONJUGATE; UNCLASSIFIED DRUG;

ACUTE HEMORRHAGIC PANCREATITIS; ASYMPTOMATIC DISEASE; BLOOD COMPONENT THERAPY; BLOOD STORAGE; BRADYCARDIA; COLLOID; CRYSTALLOID; DIMERIZATION; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMORRHAGIC SHOCK; HUMAN; HYPERTENSION; IMMUNOMODULATION; INFECTION; KIDNEY FAILURE; MORTALITY; OXYGEN AFFINITY; PAIN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; SIDE EFFECT; TISSUE OXYGENATION; TRANSFUSION RELATED ACUTE LUNG INJURY; UNSPECIFIED SIDE EFFECT;

ANIMALS; BLOOD SUBSTITUTES; CLINICAL TRIALS AS TOPIC; ERYTHROCYTE TRANSFUSION; HEMODYNAMICS; HEMOGLOBINS; HUMANS; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 84857064605     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.09.020     Document Type: Review

References (82)

1. Greenburg A.G. The ideal blood substitute. Crit Care Clin 2009, 25:415-424.
2. Cohn C.S., Cushing M.M. Oxygen therapeutics: perfluorocarbons and blood substitute safety. Crit Care Clin 2009, 25:399-414.
3. Baudin-Creuza V., Chauvierre C., Domingues E., et al. Octamers and nanoparticles as hemoglobin based blood substitutes. Biochim Biophys Acta 2008, 1784:1448-1453.
4. Fronticelli C., Koehler R.C. Design of recombinant hemoglobins for use in transfusion fluids. Crit Care Clin 2009, 25:357-371.
5. Sakai H., Sou K., Horinouchi H., Kobayashi K., Tsuchida E. Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions. J Intern Med 2008, 263:4-15.
6. Santry H.P., Alam H.B. Fluid resuscitation: past, present, and the future. Shock 2010, 33:229-241.
7. Cotton B.A., Guy J.S., Morris J.A., Abumrad N.N. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006, 26:115-121.
8. Ayuste E.C., Chen H., Koustova E., et al. Hepatic and pulmonary apoptosis after hemorrhagic shock in swine can be reduced through modifications of conventional Ringer's solution. J Trauma 2006, 60:52-63.
9. Rhee P., Burris D., Kaufmann C., et al. Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma 1998, 44:313-319.
10. Valeri C.R., Ragno G. The effects of preserved red blood cells on the severe adverse events observed in patients infused with hemoglobin based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 2008, 36:3-18.
11. Perel P., Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007, CD000567.
12. Creteur J., Vincent J.L. Potential uses of hemoglobin-based oxygen carriers in critical care medicine. Crit Care Clin 2009, 25:311-324.
13. Sullivan M.T., Cotten R., Read E.J., Wallace E.L. Blood collection and transfusion in the United States in 2001. Transfusion 2007, 47:385-394.
14. Hess J.R. An update on solutions for red cell storage. Vox Sang 2006, 91:13-19.
15. Salazar Vazquez B.Y., Wettstein R., Cabrales P., Tsai A.G., Intaglietta M. Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation. Biochim Biophys Acta 2008, 1784:1421-1427.
16. Eastman A.L., Minei J.P. Comparison of hemoglobin-based oxygen carriers to stored human red blood cells. Crit Care Clin 2009, 25:303-310.
17. Nakao M., Nakao T., Yamazoe S. Adenosine triphosphate and maintenance of shape of the human red cells. Nature 1960, 187:945-946.
18. Bennett-Guerrero E., Veldman T.H., Doctor A., et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007, 104:17063-17068.
19. d'Almeida M.S., Jagger J., Duggan M., White M., Ellis C., Chin-Yee I.H. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion. Transfus Med 2000, 10:291-303.
20. Zallen G., Offner P.J., Moore E.E., et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999, 178:570-572.
21. Offner P.J., Moore E.E., Biffl W.L., Johnson J.L., Silliman C.C. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002, 137:711-716. discussion 6-7.
22. Vamvakas E.C., Carven J.H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999, 39:701-710.
23. Purdy F.R., Tweeddale M.G., Merrick P.M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997, 44:1256-1261.
24. Allain J.P., Stramer S.L., Carneiro-Proietti A.B., et al. Transfusion-transmitted infectious diseases. Biologicals 2009, 37:71-77.
25. Wagner S.J. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004, 86:157-163.
26. Gunst M.A., Minei J.P. Transfusion of blood products and nosocomial infection in surgical patients. Curr Opin Crit Care 2007, 13:428-432.
27. Hensler T., Heinemann B., Sauerland S., et al. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 2003, 20:497-502.
28. Brittingham T.E., Chaplin H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. J Am Med Assoc 1957, 165:819-825.
29. Stack G., Snyder E.L. Cytokine generation in stored platelet concentrates. Transfusion 1994, 34:20-25.
30. Looney M.R., Gropper M.A., Matthay M.A. Transfusion-related acute lung injury: a review. Chest 2004, 126:249-258.
31. Silliman C.C., Ambruso D.R., Boshkov L.K. Transfusion-related acute lung injury. Blood 2005, 105:2266-2273.
32. Rana R., Fernandez-Perez E.R., Khan S.A., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006, 46:1478-1483.
33. Amberson W.R., Mulder A.G., Steggerda F.R., Flexner J., Pankratz D.S. Mammalian life without red blood corpuscles. Science 1933, 78:106-107.
34. Rother R.P., Bell L., Hillmen P., Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. J Am Med Assoc 2005, 293:1653-1662.
35. Urbaitis B.K., Razynska A., Corteza Q., Fronticelli C., Bucci E. Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins. J Lab Clin Med 1991, 117:115-121.
36. Riess J.G. Oxygen carriers (" blood substitutes" ) - raison d'etre, chemistry, and some physiology. Chem Rev 2001, 101:2797-2920.
37. Wallis J.P. Nitric oxide and blood: a review. Transfus Med 2005, 15:1-11.
38. Buehler P.W., Alayash A.I. All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta 2008, 1784:1378-1381.
39. Doherty D.H., Doyle M.P., Curry S.R., et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998, 16:672-676.
40. Olson J.S., Foley E.W., Rogge C., Tsai A.L., Doyle M.P., Lemon D.D. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004, 36:685-697.
41. Winslow R.M. Cell-free oxygen carriers: scientific foundations, clinical development, and new directions. Biochim Biophys Acta 2008, 1784:1382-1386.
42. Rohlfs R.J., Bruner E., Chiu A., et al. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 1998, 273:12128-12134.
43. Lindbom L., Tuma R.F., Arfors K.E. Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle. Microvasc Res 1980, 19:197-208.
44. McCarthy M.R., Vandegriff K.D., Winslow R.M. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem 2001, 92:103-117.
45. Winslow R.M., Gonzales A., Gonzales M.L., et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 1998, 85:993-1003.
46. Gaucher-Di Stasio C., Paternotte E., Prin-Mathieu C., et al. The importance of the effect of shear stress on endothelial cells in determining the performance of hemoglobin based oxygen carriers. Biomaterials 2009, 30:445-451.
47. Wettstein R., Tsai A.G., Erni D., Winslow R.M., Intaglietta M. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 2003, 31:1824-1830.
48. Gomez-Jimenez J., Salgado A., Mourelle M., et al. l-Arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995, 23:253-258.
49. Buehler P.W., D'Agnillo F., Schaer D.J. Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design. Trends Mol Med 2010, 16:447-457.
50. Schafer A., Wiesmann F., Neubauer S., Eigenthaler M., Bauersachs J., Channon K.M. Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 2004, 109:1819-1822.
51. Natanson C., Kern S.J., Lurie P., Banks S.M., Wolfe S.M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. J Am Med Assoc 2008, 299:2304-2312.
52. Silverman T.A., Weiskopf R.B. Hemoglobin-based oxygen carriers: current status and future directions. Anesthesiology 2009, 111:946-963.
53. Napolitano L.M. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?. Crit Care Clin 2009, 25:279-301.
54. Griffiths E., Cortes A., Gilbert N., Stevenson P., MacDonald S., Pepper D. Haemoglobin-based blood substitutes and sepsis. Lancet 1995, 345:158-160.
55. Nelson D., Azari M., Brown R., et al. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies. Biomater Artif Cells Immobil Biotechnol 1992, 20:423-427.
56. Meisner F.G., Kemming G.I., Habler O.P., et al. Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit. Crit Care Med 2001, 29:829-838.
57. Cole D.J., Schell R.M., Drummond J.C., Reynolds L. Focal cerebral ischemia in rats. Effect of hypervolemic hemodilution with diaspirin cross-linked hemoglobin versus albumin on brain injury and edema. Anesthesiology 1993, 78:335-342.
58. Sloan E.P., Koenigsberg M., Gens D., et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. J Am Med Assoc 1999, 282:1857-1864.
59. Saxena R., Wijnhoud A.D., Carton H., et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999, 30:993-996.
60. Schubert A., Przybelski R.J., Eidt J.F., et al. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesth Analg 2003, 97:323-332.
61. Lamy M.L., Daily E.K., Brichant J.F., et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology 2000, 92:646-656.
62. Hughes G.S., Antal E.J., Locker P.K., Francom S.F., Adams W.J., Jacobs E.E. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1996, 24:756-764.
63. LaMuraglia G.M., O'Hara P.J., Baker W.H., et al. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000, 31:299-308.
64. Sprung J., Kindscher J.D., Wahr J.A., et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth Analg 2002, 94:799-808.
65. Levy J.H., Goodnough L.T., Greilich P.E., et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002, 124:35-42.
66. Jahr J.S., Mackenzie C., Pearce L.B., Pitman A., Greenburg A.G. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008, 64:1484-1497.
67. Jahr J.S., Moallempour M., Lim J.C. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation). Expert Opin Biol Ther 2008, 8:1425-1433.
68. Gould S.A., Moore E.E., Hoyt D.B., et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998, 187:113-120. discussion 20-2.
69. Gould S.A., Moore E.E., Hoyt D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002, 195:445-452. discussion 52-5.
70. Gould S.A., Moore E.E., Moore F.A., et al. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery. J Trauma 1997, 43:325-331. discussion 31-2.
71. Johnson J.L., Moore E.E., Gonzalez R.J., Fedel N., Partrick D.A., Silliman C.C. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. J Trauma 2003, 54:133-139. discussion 9-40.
72. Moore E.E., Moore F.A., Fabian T.C., et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009, 208:1-13.
73. Vandegriff K.D., Malavalli A., Wooldridge J., Lohman J., Winslow R.M. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 2003, 43:509-516.
74. Cabrales P., Tsai A.G., Intaglietta M. Balance between vasoconstriction and enhanced oxygen delivery. Transfusion 2008, 48:2087-2095.
75. 2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 2005, 33:1-12.
76. Young M.A., Riddez L., Kjellstrom B.T., et al. MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med 2005, 33:1794-1804.
77. Olofsson C., Ahl T., Johansson T., et al. A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology 2006, 105:1153-1163.
78. Olofsson C.I., Gorecki A.Z., Dirksen R., et al. Evaluation of MP4OX for prevention of perioperative hypotension in patients undergoing primary hip arthroplasty with spinal anesthesia: a randomized, double-blind, multicenter study. Anesthesiology 2011, 114:1048-1063.
79. van der Linden P., Gazdzik T.S., Jahoda D., et al. A double-blind, randomized, multicenter study of MP4OX for treatment of perioperative hypotension in patients undergoing primary hip arthroplasty under spinal anesthesia. Anesth Analg 2011, 112:759-773.
80. Zuckerbraun B.S., McCloskey C.A., Gallo D., et al. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock 2005, 23:527-532.
81. Vandegriff K.D., Young M.A., Lohman J., et al. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol 2008, 154:1649-1661.
82. Kinasewitz G.T., Privalle C.T., Imm A., et al. Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock. Crit Care Med 2008, 36:1999-2007.